Carotid endarterectomy surgeon volumes in contemporary practice: A comparison to randomized trial inclusion criteria.


Journal

American journal of surgery
ISSN: 1879-1883
Titre abrégé: Am J Surg
Pays: United States
ID NLM: 0370473

Informations de publication

Date de publication:
07 2021
Historique:
received: 10 03 2020
revised: 15 09 2020
accepted: 04 11 2020
pubmed: 24 11 2020
medline: 4 8 2021
entrez: 23 11 2020
Statut: ppublish

Résumé

Clinical decisions regarding the utility of carotid revascularization are informed by randomized controlled trial (RCT) results. However, RCTs generally require participating surgeons to meet strict inclusion criteria with respect to procedure volume. The purpose of this study was to compare annual surgeon volume for carotid endarterectomy (CEA) in contemporary practice to RCT inclusion thresholds. Surgeon volume thresholds were identified in 17 RCTs evaluating the efficacy of CEA (1986-present, n = 17). Contemporary annual surgeon volumes (2012-2017) were identified by aggregating data from the Medicare Provider Utilization Database and Healthcare Cost and Utilization Project Network (HCUP), and compared to RCT inclusion thresholds. Further comparisons were performed over time, and across specialties (i.e., vascular surgeon vs. other, based on board certification associated with provider NPI). Minimal surgeon volume in 17 RCTs ranged from 10 to 25 CEA annually when specific case volumes were required. From 2012 to 2017, CEA incidence in Medicare beneficiaries declined from 68,608 to 56,004 and became increasingly consolidated in fewer providers (7,331 vs. 6,626). However, in 2016 only 26.2% of surgeons performing CEA in Medicare beneficiaries would have met the least stringent volume requirement (10 CEA/year). Only 6.5% of surgeons performing CEA met the most stringent RCT volume threshold (25 cases/year) during the same time period. In 2017, 819 vascular surgeons (25.5% of those certified in the specialty) performed >10 CEA in Medicare beneficiaries. The majority of surgeons performing CEA do not meet the annual volume thresholds required for participation in the RCTs that have evaluated the efficacy of carotid revascularization. Given the established volume-outcome relationship in CEA, the disparity between surgeon experience in the context of RCTs versus contemporary practice is concerning. These findings have potential implications for informed decision-making, hospital privileging, and regionalization of care.

Sections du résumé

BACKGROUND
Clinical decisions regarding the utility of carotid revascularization are informed by randomized controlled trial (RCT) results. However, RCTs generally require participating surgeons to meet strict inclusion criteria with respect to procedure volume. The purpose of this study was to compare annual surgeon volume for carotid endarterectomy (CEA) in contemporary practice to RCT inclusion thresholds.
METHODS
Surgeon volume thresholds were identified in 17 RCTs evaluating the efficacy of CEA (1986-present, n = 17). Contemporary annual surgeon volumes (2012-2017) were identified by aggregating data from the Medicare Provider Utilization Database and Healthcare Cost and Utilization Project Network (HCUP), and compared to RCT inclusion thresholds. Further comparisons were performed over time, and across specialties (i.e., vascular surgeon vs. other, based on board certification associated with provider NPI).
RESULTS
Minimal surgeon volume in 17 RCTs ranged from 10 to 25 CEA annually when specific case volumes were required. From 2012 to 2017, CEA incidence in Medicare beneficiaries declined from 68,608 to 56,004 and became increasingly consolidated in fewer providers (7,331 vs. 6,626). However, in 2016 only 26.2% of surgeons performing CEA in Medicare beneficiaries would have met the least stringent volume requirement (10 CEA/year). Only 6.5% of surgeons performing CEA met the most stringent RCT volume threshold (25 cases/year) during the same time period. In 2017, 819 vascular surgeons (25.5% of those certified in the specialty) performed >10 CEA in Medicare beneficiaries.
CONCLUSIONS
The majority of surgeons performing CEA do not meet the annual volume thresholds required for participation in the RCTs that have evaluated the efficacy of carotid revascularization. Given the established volume-outcome relationship in CEA, the disparity between surgeon experience in the context of RCTs versus contemporary practice is concerning. These findings have potential implications for informed decision-making, hospital privileging, and regionalization of care.

Identifiants

pubmed: 33223073
pii: S0002-9610(20)30684-X
doi: 10.1016/j.amjsurg.2020.11.004
pii:
doi:

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

241-244

Informations de copyright

Published by Elsevier Inc.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors have no conflicts of interest to report.

Auteurs

Matthew D Breite (MD)

Mayo Clinic Arizona Division of Vascular Surgery, 5777 East Mayo Boulevard, Phoenix, AZ, 85054, United States. Electronic address: breite.matthew@mayo.edu.

Christine N Breite (CN)

Mayo Clinic Arizona Division of Vascular Surgery, 5777 East Mayo Boulevard, Phoenix, AZ, 85054, United States.

William W Sheaffer (WW)

Mayo Clinic Arizona Division of Vascular Surgery, 5777 East Mayo Boulevard, Phoenix, AZ, 85054, United States.

Ina Y Soh (IY)

Mayo Clinic Arizona Division of Vascular Surgery, 5777 East Mayo Boulevard, Phoenix, AZ, 85054, United States.

Victor J Davila (VJ)

Mayo Clinic Arizona Division of Vascular Surgery, 5777 East Mayo Boulevard, Phoenix, AZ, 85054, United States.

Samuel R Money (SR)

Mayo Clinic Arizona Division of Vascular Surgery, 5777 East Mayo Boulevard, Phoenix, AZ, 85054, United States.

William M Stone (WM)

Mayo Clinic Arizona Division of Vascular Surgery, 5777 East Mayo Boulevard, Phoenix, AZ, 85054, United States.

Stephen J Tarsa (SJ)

Mayo Clinic Arizona Division of Vascular Surgery, 5777 East Mayo Boulevard, Phoenix, AZ, 85054, United States.

Andrew J Meltzer (AJ)

Mayo Clinic Arizona Division of Vascular Surgery, 5777 East Mayo Boulevard, Phoenix, AZ, 85054, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH